Abstract
We have evaluated a new enzyme immunoassay (EIA) to measure IgG antibodies (Abs) to HIV in patients with AIDS, AIDS-related complex (ARC), AIDS contacts (AC), and low risk controls. Twenty-nine (94%) of 31 AIDS, 27 (96%) of 26 ARC, 12 (54%) of 22 AC, and 1 (2%) of 60 control patients were anti-HIV Ab positive by this assay. Positive results were confirmed by Western blot analysis. The EIA for anti-HIV evaluated in this study is sensitive and specific in identifying individuals who have been infected by this retrovirus.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 369-375 |
| Number of pages | 7 |
| Journal | AIDS Research |
| Volume | 2 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1986 |
| Externally published | Yes |
ASJC Scopus subject areas
- Immunology
- Virology
Fingerprint
Dive into the research topics of 'Sensitivity and Specificity of an HIV Antibody Assay'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS